These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3149342)

  • 1. [Treatment of non-A, non-B hepatitis with glycyrrhizin].
    Ohta W; Iwamura K
    Nihon Rinsho; 1988 Dec; 46(12):2681-8. PubMed ID: 3149342
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1022-5. PubMed ID: 7563661
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
    Su XS; Chen HM; Wang LH; Jiang CF; Liu JH; Zhao MQ; Ma XH; Zhao YC; Han DW
    J Tradit Chin Med; 1984 Jun; 4(2):127-32. PubMed ID: 6567725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
    Zhang ZH; Yang ZH
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):150-1, 157, 132-3. PubMed ID: 3416396
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of non-A, non-B hepatitis with immunopotentiator OK-432].
    Shimada Y; Hirakawa H; Fukumoto S; Nagaoka S
    Nihon Rinsho; 1988 Dec; 46(12):2689-702. PubMed ID: 3149343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glycyrrhizin for the treatment of allergic diseases and chronic hepatitis].
    Zeuzem S
    Dtsch Med Wochenschr; 1998 Mar; 123(12):372. PubMed ID: 9551042
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic hepatitis B. Part 2: Effect of glycyrrhizic acid on the course of illness].
    Eisenburg J
    Fortschr Med; 1992 Jul; 110(21):395-8. PubMed ID: 1516877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
    Hayashi J; Kashiwagi S; Noguchi A; Ikematsu H; Tsuda H; Tsuji Y; Motomura M
    Clin Ther; 1989; 11(1):161-9. PubMed ID: 2497983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
    Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H
    Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of chronic hepatitis other than interferon therapy].
    Sainokami S; Hino K; Niwa H
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):235-9. PubMed ID: 7963944
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis.
    Tanaka N; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Aikawa T; Osuga T; Iga T
    Biopharm Drug Dispos; 1993 Oct; 14(7):609-14. PubMed ID: 8251615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of therapeutic effect of catergen in viral hepatitis].
    Boroń P; Boroń-Kaczmarska A; Sokolewicz-Bobrowska E; Szpakowicz T; Nadowska K
    Pol Tyg Lek; 1979 Aug; 34(33):1315-7. PubMed ID: 117435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic active non-A, non-B hepatitis].
    Moreira Vicente VF; Barcena Marugán R; Hernández Ranz F; Milicua Salamero JM; Martín Scapa MA; Ruiz del Arbol L; Bueno Vallejo R; Gil Grande LA; Suárez García E; García Plaza A
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):270-86. PubMed ID: 6419304
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chronic viral hepatitis: the end of the beginning?
    Dusheiko G
    Br J Hosp Med; 1994 Jun 15-Jul 12; 52(1):8-11. PubMed ID: 7524985
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.
    Hayashi J; Kajiyama W; Noguchi A; Nakashima K; Hirata M; Hayashi S; Kashiwagi S
    Gastroenterol Jpn; 1991 Dec; 26(6):742-6. PubMed ID: 1765247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycyrrhizic acid].
    Tolstikov GA; Baltina LA; Shul'ts EE; Pokrovskił AG
    Bioorg Khim; 1997 Sep; 23(9):691-709. PubMed ID: 9441592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intravenous stronger neo-minophagen C and S-adenosyl-L-methionine in treatment of pregnant woman with chronic hepatitis B: a pilot study.
    Sun QF; Ding JG; Wang XF; Fu RQ; Yang JX; Hong L; Xu XJ; Wang JR; Wu JG; Xu DZ
    Med Sci Monit; 2010 Aug; 16(8):PR9-14. PubMed ID: 20671623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural course and trial of treatment for infantile liver dysfunction associated with cytomegalovirus infections.
    Numazaki K; Chiba S
    In Vivo; 1993; 7(6A):477-80. PubMed ID: 8193264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.